Coeptis Therapeutics, Inc. Operating Expenses
Coeptis Therapeutics, Inc. reported Operating Expenses of $5.57 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-11-08
- Coeptis Therapeutics, Inc. operating expenses for the quarter ending 2022-09-30 was $5.57M, a 19.85% decline year-over-year.
- Coeptis Therapeutics, Inc. operating expenses for the quarter ending 2022-06-30 was $9.81M, a 273.96% increase year-over-year.
- Coeptis Therapeutics, Inc. operating expenses for the quarter ending 2022-03-31 was $15.77M, a 788.47% increase year-over-year.
- Coeptis Therapeutics, Inc. operating expenses for the quarter ending 2021-12-31 was $2.96M, a 8.15% decline year-over-year.
- Coeptis Therapeutics, Inc. operating expenses for fiscal 2021 was $14.31M, a 141.37% increase from fiscal 2020.
- Coeptis Therapeutics, Inc. operating expenses for fiscal 2020 was $5.93M.
| Period end | Operating Expenses 3 month | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 10 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $5.57M 10-Q · filed 2022-11-08 | $15.38M derived: sum of 2 quarters · filed 2022-11-08 | $31.15M 10-Q · filed 2022-11-08 | $34.11M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2022-06-30 | $9.81M 10-Q · filed 2022-08-02 | $25.58M 10-Q · filed 2022-08-02 | $28.55M derived: sum of 3 quarters · filed 2022-08-02 | $35.49M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2022-03-31 | $15.77M 10-Q · filed 2022-05-12 | $18.73M derived: sum of 2 quarters · filed 2022-05-12 | $25.68M derived: sum of 3 quarters · filed 2022-11-08 | $28.30M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $9.91M derived: sum of 2 quarters · filed 2022-11-08 | $12.53M derived: sum of 3 quarters · filed 2022-11-08 | $14.31M 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | $6.95M 10-Q · filed 2022-11-08 | $9.57M derived: sum of 2 quarters · filed 2022-11-08 | $11.35M 10-Q · filed 2022-11-08 | $14.57M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $2.62M 10-Q · filed 2022-08-02 | $4.40M 10-Q · filed 2022-08-02 | $7.62M derived: sum of 3 quarters · filed 2022-08-02 | |||||
| 2021-03-31 | $1.78M 10-Q · filed 2022-05-12 | $5.00M derived: sum of 2 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $566.68K 10-KT · filed 2021-05-11 | $5.93M 10-K · filed 2022-03-11 | |||||
| 2020-11-30 | $487.37K 10-Q · filed 2021-01-11 | $508.11K 10-Q · filed 2021-01-11 | ||||||
| 2020-09-30 | $1.62M 10-Q · filed 2021-11-15 | $2.70M 10-Q · filed 2021-11-15 | ||||||
| 2020-08-31 | $12.12K 10-Q/A · filed 2020-11-23 | $20.74K 10-Q/A · filed 2020-11-23 | ||||||
| 2020-06-30 | $701.74K 10-Q · filed 2021-08-16 | $1.09M 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | $400.91K 10-Q/A · filed 2021-05-18 | |||||||
| 2019-12-31 | $99.00 10-KT · filed 2021-05-11 | |||||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 | $0.00 derived: sum of 2 quarters · filed 2021-01-11 | $99.00 10-Q · filed 2021-01-11 | |||||
| 2019-08-31 | $0.00 10-Q/A · filed 2020-11-23 | $99.00 10-Q/A · filed 2020-11-23 |